4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-25-000290
Options or other derivatives
- President and CEO acquired 179,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BLATT LAWRENCE · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-16 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +179,800 | 179,800 | D |
Loading xslF345X05/form4.xml…